407 related articles for article (PubMed ID: 26409255)
1. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.
Achiou Z; Toumi H; Touvier J; Boudenot A; Uzbekov R; Ominsky MS; Pallu S; Lespessailles E
Bone; 2015 Dec; 81():691-701. PubMed ID: 26409255
[TBL] [Abstract][Full Text] [Related]
2. Free-fall landing and interval running have different effects on trabecular bone mass and microarchitecture, serum osteocalcin, biomechanical properties,
Boudenot A; Pallu S; Uzbekov R; Dolleans E; Toumi H; Lespessailles E
Appl Physiol Nutr Metab; 2021 Dec; 46(12):1525-1534. PubMed ID: 34370961
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
6. Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia.
Maurel DB; Jaffre C; Rochefort GY; Aveline PC; Boisseau N; Uzbekov R; Gosset D; Pichon C; Fazzalari NL; Pallu S; Benhamou CL
Bone; 2011 Sep; 49(3):543-52. PubMed ID: 21689804
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.
Qin W; Li X; Peng Y; Harlow LM; Ren Y; Wu Y; Li J; Qin Y; Sun J; Zheng S; Brown T; Feng JQ; Ke HZ; Bauman WA; Cardozo CC
J Bone Miner Res; 2015 Nov; 30(11):1994-2004. PubMed ID: 25974843
[TBL] [Abstract][Full Text] [Related]
8. The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats.
Wu J; Cai XH; Qin XX; Liu YX
Z Gerontol Geriatr; 2018 Jul; 51(5):550-556. PubMed ID: 28364259
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
Zhang D; Hu M; Chu T; Lin L; Wang J; Li X; Ke HZ; Qin YX
Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats.
Suen PK; Zhu TY; Chow DH; Huang L; Zheng LZ; Qin L
Sci Rep; 2015 Oct; 5():15632. PubMed ID: 26494536
[TBL] [Abstract][Full Text] [Related]
11. Regular exercise limits alcohol effects on trabecular, cortical thickness and porosity, and osteocyte apoptosis in the rat.
Maurel DB; Boisseau N; Pallu S; Rochefort GY; Benhamou CL; Jaffre C
Joint Bone Spine; 2013 Oct; 80(5):492-8. PubMed ID: 23380443
[TBL] [Abstract][Full Text] [Related]
12. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
Suen PK; He YX; Chow DH; Huang L; Li C; Ke HZ; Ominsky MS; Qin L
J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
[TBL] [Abstract][Full Text] [Related]
14. Effects of anti-sclerostin antibody and running on bone remodeling and strength.
Toumi H; Benaitreau D; Pallu S; Mazor M; Hambli R; Ominsky M; Lespessailles E
Bone Rep; 2015 Jun; 2():52-58. PubMed ID: 28377954
[TBL] [Abstract][Full Text] [Related]
15. Cumulative Effects of Strontium Ranelate and Impact Exercise on Bone Mass in Ovariectomized Rats.
Aveline P; Cesaro A; Mazor M; M Best T; Lespessailles E; Toumi H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809778
[TBL] [Abstract][Full Text] [Related]
16. Effect of interval-training exercise on subchondral bone in a chemically-induced osteoarthritis model.
Boudenot A; Presle N; Uzbekov R; Toumi H; Pallu S; Lespessailles E
Osteoarthritis Cartilage; 2014 Aug; 22(8):1176-85. PubMed ID: 24928318
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Chen H; Xu X; Liu M; Zhang W; Ke HZ; Qin A; Tang T; Lu E
Bone; 2015 Jul; 76():141-8. PubMed ID: 25868799
[TBL] [Abstract][Full Text] [Related]
18. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
[TBL] [Abstract][Full Text] [Related]
19. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
[TBL] [Abstract][Full Text] [Related]
20. Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength.
Sinder BP; White LE; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
Osteoporos Int; 2014 Aug; 25(8):2097-107. PubMed ID: 24803333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
